Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: A meta-analysis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: A meta-analysis. / Møldrup, Claus; Østergaard, Svetlana.

I: Journal of Affective Disorders, Bind 131, Nr. 1-3, 2011, s. 24-36.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Møldrup, C & Østergaard, S 2011, 'Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: A meta-analysis', Journal of Affective Disorders, bind 131, nr. 1-3, s. 24-36. https://doi.org/10.1016/j.jad.2010.08.014

APA

Møldrup, C., & Østergaard, S. (2011). Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: A meta-analysis. Journal of Affective Disorders, 131(1-3), 24-36. https://doi.org/10.1016/j.jad.2010.08.014

Vancouver

Møldrup C, Østergaard S. Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: A meta-analysis. Journal of Affective Disorders. 2011;131(1-3):24-36. https://doi.org/10.1016/j.jad.2010.08.014

Author

Møldrup, Claus ; Østergaard, Svetlana. / Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: A meta-analysis. I: Journal of Affective Disorders. 2011 ; Bind 131, Nr. 1-3. s. 24-36.

Bibtex

@article{4f1c81b43d3e41428f968e45b634dbc0,
title = "Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: A meta-analysis",
abstract = "Background: To investigate the most effective duration of combined psychotherapy and pharmacotherapy for achieving remission and preventing relapse in depressive patients compared to pharmacotherapy alone.Methods: A systematic review of English articles using PubMed, EMBASE, Web of Science, the Cochrane Library, and PsychINFO was performed in September 2009. Clinical studies comparing pharmacotherapy alone with pharmacotherapy in combination with a psychological intervention for depression treatment that reported response, remission or relapse as outcomes were included in the analysis. For each of the studies, clinical binary outcomes such as response, remission or relapse were extracted.Result: All pooled analyses were based on random-effects models. Twenty-one articles describing the influence of additional psychotherapy on remission and 15 articles reporting the influence on relapse in depression were included in the analysis. Patients receiving combined treatment experienced remission more often than those receiving pharmacotherapy alone, with the highest odds ratio OR, 2,36;95{\%}Cl, 1.58-3.55 observed at 4 months after commencing the treatment. Patients receiving pharmacotherapy alone also demonstrated a higher risk for relapse compared to those receiving combined treatment.Limitations: we restricted our search to only English language publications. Studies investigating relapse or recurrence rates are often of small size.Conclusion: Pharmacotherapy enhanced with psychotherapy is associated with a higher probability of remission and a lower risk of relapse, as compared to antidepressants alone for depression treatment. Receiving psychotherapy in both the acute and continuation phases is the most effective option. Further research is needed to investigate the influence of additional psychotherapy on different patients.",
keywords = "Former Faculty of Pharmaceutical Sciences",
author = "Claus M{\o}ldrup and Svetlana {\O}stergaard",
year = "2011",
doi = "10.1016/j.jad.2010.08.014",
language = "English",
volume = "131",
pages = "24--36",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "1-3",

}

RIS

TY - JOUR

T1 - Optimal duration of combined psychotherapy and pharmacotherapy for patients with moderate and severe depression: A meta-analysis

AU - Møldrup, Claus

AU - Østergaard, Svetlana

PY - 2011

Y1 - 2011

N2 - Background: To investigate the most effective duration of combined psychotherapy and pharmacotherapy for achieving remission and preventing relapse in depressive patients compared to pharmacotherapy alone.Methods: A systematic review of English articles using PubMed, EMBASE, Web of Science, the Cochrane Library, and PsychINFO was performed in September 2009. Clinical studies comparing pharmacotherapy alone with pharmacotherapy in combination with a psychological intervention for depression treatment that reported response, remission or relapse as outcomes were included in the analysis. For each of the studies, clinical binary outcomes such as response, remission or relapse were extracted.Result: All pooled analyses were based on random-effects models. Twenty-one articles describing the influence of additional psychotherapy on remission and 15 articles reporting the influence on relapse in depression were included in the analysis. Patients receiving combined treatment experienced remission more often than those receiving pharmacotherapy alone, with the highest odds ratio OR, 2,36;95%Cl, 1.58-3.55 observed at 4 months after commencing the treatment. Patients receiving pharmacotherapy alone also demonstrated a higher risk for relapse compared to those receiving combined treatment.Limitations: we restricted our search to only English language publications. Studies investigating relapse or recurrence rates are often of small size.Conclusion: Pharmacotherapy enhanced with psychotherapy is associated with a higher probability of remission and a lower risk of relapse, as compared to antidepressants alone for depression treatment. Receiving psychotherapy in both the acute and continuation phases is the most effective option. Further research is needed to investigate the influence of additional psychotherapy on different patients.

AB - Background: To investigate the most effective duration of combined psychotherapy and pharmacotherapy for achieving remission and preventing relapse in depressive patients compared to pharmacotherapy alone.Methods: A systematic review of English articles using PubMed, EMBASE, Web of Science, the Cochrane Library, and PsychINFO was performed in September 2009. Clinical studies comparing pharmacotherapy alone with pharmacotherapy in combination with a psychological intervention for depression treatment that reported response, remission or relapse as outcomes were included in the analysis. For each of the studies, clinical binary outcomes such as response, remission or relapse were extracted.Result: All pooled analyses were based on random-effects models. Twenty-one articles describing the influence of additional psychotherapy on remission and 15 articles reporting the influence on relapse in depression were included in the analysis. Patients receiving combined treatment experienced remission more often than those receiving pharmacotherapy alone, with the highest odds ratio OR, 2,36;95%Cl, 1.58-3.55 observed at 4 months after commencing the treatment. Patients receiving pharmacotherapy alone also demonstrated a higher risk for relapse compared to those receiving combined treatment.Limitations: we restricted our search to only English language publications. Studies investigating relapse or recurrence rates are often of small size.Conclusion: Pharmacotherapy enhanced with psychotherapy is associated with a higher probability of remission and a lower risk of relapse, as compared to antidepressants alone for depression treatment. Receiving psychotherapy in both the acute and continuation phases is the most effective option. Further research is needed to investigate the influence of additional psychotherapy on different patients.

KW - Former Faculty of Pharmaceutical Sciences

U2 - 10.1016/j.jad.2010.08.014

DO - 10.1016/j.jad.2010.08.014

M3 - Journal article

C2 - 20950863

VL - 131

SP - 24

EP - 36

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 1-3

ER -

ID: 38373342